| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2005-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1af984bccc15be4dd1a70352469523d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4facabeeb954921161581e0ddd778df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5db4e8942f2a90510fbd98cc8f08d860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03bf8d5d2471d21b3c7ab5c73d100357 |
| publicationDate |
2007-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1833502-A1 |
| titleOfInvention |
Pharmaceutical composition for the treatment of invasive pulmonary aspergillosis |
| abstract |
The present invention provides a pharmaceutical composition comprising purified human mannan-binding lectin (MBL) optionally along with carriers administered at a unit dose in the range of 1.0µg-5.0µg /20kg body weight. Further, it also deals with a method and use thereof for the treatment of invasive pulmonary aspergillosis using said composition. |
| priorityDate |
2004-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |